Doximity (DOCS) Stock: Buy, Sell, or Hold?
DOCS - Doximity, Inc.
$28.50
0.16 (0.56%)
▲
5d:
+9.45%
30d:
+8.16%
90d:
+30.38%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When DOCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: DOCS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: DOCS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$34.97
Based on 4.4% avg growth
INTRINSIC VALUE TODAY
$21.72
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DOCS is currently trading at $28.50, which is considered extended relative to its 30-day fair value range of $25.13 to $27.12. The stock's valuation (Forward PE: 17.6) is in line with its historical norms (17.4). At these levels, the market is pricing in 0.3% annual earnings growth.
Technical Outlook: Technically, DOCS is in a strong uptrend. The price is approaching resistance at $28.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DOCS scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DOCS is in a strong uptrend. The price is approaching resistance at $28.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DOCS scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$25.13 -
$27.12
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
22.4%
Protect Your Profits
Holding DOCS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.1% above its trading range)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($29.67)
- BULLISH: Expecting earnings turnaround to 0.3% growth with 7.3% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$25.13 -
$27.12
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$25.33
Resistance Level
$28.95
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.58
Wall Street Target
$29.67
(+4.1%)
Revenue Growth (YoY)
7.3%
Earnings Growth (YoY)
-51.9%
Profit Margin
25.5%
Valuation Premium vs History
+0.3% premium
PE vs Historical
17.6 vs 17.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.3%
(market-implied from PE analysis)
1-Year Target
$28.59
(+0%)
2-Year Target
$28.67
(+1%)
3-Year Target
$28.76
(+1%)
3-Yr Target (if PE normalizes)
(PE: 18→17)
PE COMPRESSION
$28.45
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 4.8%)
$38.05
(+34%)
Base:
(SPY PE: 17.6, Growth: 4.8%)
$32.80
(+15%)
Bear:
(PE: 14.9, Growth: 4.8%)
$27.88
(-2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 33.34 | Current EPS (TTM): $0.85
Bull Case
$59.44
(+109%)
Analyst growth 90.7%, PE expands to 36.7
Base Case
$54.04
(+90%)
Market implied 90.7%, PE stable at 33.3
Bear Case
$19.27
(-32%)
Severe decline -20.0%, PE contracts to 28.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 01, 2026 9:32 PM ET
Data refreshes hourly during market hours. Next update: 10:32 PM
Data refreshes hourly during market hours. Next update: 10:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DOCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Siddharth Sitaram
SELL
2427 shares
2026-04-10
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 60 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 80 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 41 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 51 HOLD |
Advanced DOCS Option Strategies
Professional options setups generated by AI based on today's DOCS price and gamma walls.
